Effect of a selective CYP2C9 inhibitor on the pharmacokinetics of nateglinide in healthy subjects

Author: Sabia Helene   Sunkara Gangadhar   Ligueros-Saylan Monica   Wang Yibin   Smith Harold   McLeod James   Prasad Pratapa  

Publisher: Springer Publishing Company

ISSN: 0031-6970

Source: European Journal of Clinical Pharmacology, Vol.60, Iss.6, 2004-09, pp. : 407-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content